Immune-mediated liver injury is a central feature of hyperinflammatory diseases, such as hemophagocytic syndromes, yet the immunologic mechanisms underlying those processes are incompletely understood. In this study, we used the toll-like receptor 9 (TLR9)-mediated model of a hemophagocytic syndrome known as macrophage activation syndrome (MAS) to dissect the predominant immune cell populations infiltrating the liver during inflammation. We identified CD8 + T cells that unexpectedly produce 
Introduction
PALF is a serious, rapidly progressive syndrome, frequently requiring liver transplantation and often resulting in patient death [1, 2] . Many PALF cases result from known causes, such as acetaminophen toxicity, inherited metabolic disease, autoimmune hepatitis, or acute viral hepatitis; however, the etiology eludes specific diagnosis in nearly one-half of cases (designated iPALF) [3] . Mounting evidence suggests that dysregulated, inflammatory processes may underlie a large portion of iPALF cases. Elevated serum levels of sIL-2Ra, a marker of T cell activation, are found in ;one-half of patients with iPALF [4] . There are also striking similarities in clinical presentation between iPALF and hemophagocytic syndromes, both of which can include fever, hepatomegaly, abnormal liver function tests, BM suppression, and elevated sIL-2Ra [5] . Liver failure in these "cytokine storm" syndromes, which include FHL and MAS, is a well-recognized complication of the disease and can sometimes dominate the clinical presentation. These hemophagocytic syndromes are caused by a failure of healthy immune regulation during a reactionary inflammatory process, resulting in hypercytokinemia, hepatosplenomegaly, cytopenias, inflammatory cell infiltration in multiple organs (particularly spleen and liver), and can rapidly lead to multiorgan failure and death [6, 7] . Murine models of numerous forms of hemophagocytic syndrome, particularly variants of FHL, have implicated activated CD8 + T cells that overproduce cytokines as having a major pathogenic role [8, 9] . Interestingly, recent histologic studies of FHL and iPALF identified a predominant hepatic CD8 + T cell infiltrate in most cases [10] . Together, these findings suggest the possibility of a common immunologic mechanism responsible for liver injury in both hemophagocytic syndrome and iPALF. Inflammatory liver injury is, therefore, likely important in many scenarios.
To better understand the nature of hepatic inflammation in hemophagocytic syndrome and other immune-mediated liver diseases, we used the murine model of MAS induced by TLR9 stimulation (TLR9-MAS) to investigate liver-infiltrating immune cells [11] . We identified a large population of hepatic CD8 + T cells that surprisingly produces both IL-10 and IFN-g. This subset bears little resemblance to previously described IL-10 + CD8 + suppressor T cells. Instead, these cells arise independent of Ag stimulation and rely indirectly on IFN-g for their induction. Using extensive phenotypic and transcriptional analysis, we determined that these IL-10 + hepatic CD8 + T cells resemble activated, early effector CD8 + T cells, similar to those elicited by viral or intracellular bacterial pathogens. However, they also exhibit a particular signature of responsiveness to growth factors induced by hepatic damage. Thus, our study provides evidence that IL-10 +
CD8
+ T cells are a prominent immune cell subset at the site of liver injury in the context of systemic inflammatory disease. Future studies investigating inflammatory infiltrates in iPALF and other systemic inflammatory illnesses with liver dysfunction should include analysis of IL-10 + hepatic CD8 + T cells.
MATERIALS AND METHODS

Mice
Male and female C57BL/6, B6.SJL (B6.SJL-Ptprc ) mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Unless otherwise stated, WT refers to IL-10 reporter mice. All experiments were performed with institutional animal care and use committee approval of the University of Pennsylvania (Philadelphia, PA, USA) and Children's Hospital of Philadelphia (Philadelphia, PA, USA).
In vivo treatment
To induce TLR9-MAS, mice were injected i.p. with 50 mg CpG oligodeoxynucleotides 1826 (Integrated DNA Technologies, Coralville, IA, USA) on d 0, 2, 4, 7, and 9; control mice were injected i.p. with PBS on the same dosing schedule, and all mice were analyzed on d 10. To induce FHL, Prf1 2/2 IL-10 reporter mice were infected with 1 3 10 5 PFU LCMV-Armstrong i.p. 
Flow cytometry
Viability assays
Live (LIVE/DEAD 2 ) cells were FACS purified and cultured with BMDCs, 10 mg/ml CpG, plate-bound a-CD3/a-CD28, 50 U/ml IL-2, 0.5 ng/ml IL-12, or 10-fold, diluted TLR9-MAS serum before restaining with LIVE/DEAD and viability analysis. 
Microarrays and transcriptional analysis
RESULTS AND DISCUSSION
IL-10-producing CD8 + T cells are prominent among hepatic inflammatory infiltrates in murine hemophagocytic syndrome
The TLR9-MAS murine model of hemophagocytic syndrome results in severe liver damage, as evidenced by hepatomegaly, marked lymphohistiocytic inflammatory infiltration, and lobular necrosis [11] . To investigate this hepatotoxic effect of systemic inflammation, we first surveyed the principal immune cell populations induced by inflammation in the liver. CpG-treated TLR9-MAS mice demonstrated a mixed hepatic infiltrate with CD8 + T cell predominance (Fig. 1A) . Given the known pathogenic role of CD8 + T cells in the perforin-deficient (Prf1
)/LCMV model of FHL [8, 15] and their conspicuous presence in the livers of patients with iPALF [10] , we proceeded to characterize this intrahepatic CD8 + T cell pool.
Most hepatic CD8 + T cells in these mice were capable of producing IFN-g, the primary cytokine driving inflammation in TLR9-MAS [11] (Fig. 1B) . Surprisingly, many of these IFN-g + hepatic CD8 + T cells also produced IL-10 ( Fig. 1B) , the main negative regulator of inflammation in TLR9-MAS mice [11] . This IFN-g + IL-10 + functional profile was not observed in the absence of inflammation because hepatic CD8 + T cells obtained from PBS-treated mice showed negligible IL-10 production capacity among IFN-g + CD8 + T cells (Fig. 1B) . Having confirmed that IL-10 was produced at the protein level, we then made use of IL-10 reporter mice, which report IL-10 transcription through the production of GFP and show excellent correlation between IL-10 protein and GFP expression (Supplemental Fig. 1 ) [12] . CpG induced substantial IL-10 production by CD8 + T cells, making this subset the largest population of IL-10 producers in the livers of TLR9-MAS mice ( (Fig. 2D) . The total number of IL-10/GFP + CD8 + T cells in the livers of OT-I mice was at least as high as it was in WT mice ( We hypothesized that IL-10 + hepatic CD8 + T cells may instead rely on cytokine-mediated activation, similar to populations of effector and memory CD8 + T cells that have been described [23] [24] [25] [26] . Because IFN-g has a central role in the pathogenesis of TLR9-MAS [11, 27] , we examined the livers of CpG-injected mice deficient in IFNGR. Ifngr 2/2 IL-10 reporter mice demonstrated a lower frequency of IL-10-producing cells among hepatic CD8 + T cells than did IL-10 reporter mice (mean 25.0% vs. 45.6%, respectively), resulting in a decrement of 50% in total frequency (Fig. 2E ). To determine whether that partial dependence on IFN-g was CD8 + T cell intrinsic or extrinsic, we generated BM chimeras using donor cells from IL-10 reporter (WT) mice, Ifngr 2/2 IL-10 reporter (Ifngr 2/2 ) mice, or both.
Consistent with data in the global IFNGR knockout (Fig. 2E) Together, these data suggest that TLR9-induced IL-10 + hepatic CD8 + T cells do not resemble previously described populations of IL-10-producing CD8 + T cells and may, therefore, represent a unique subset of CD8 + T cells. This study provides, to our knowledge, the first description of the induction of IL-10 production by CD8 + T cells in an Ag-independent manner. These results, therefore, suggest that Ag-independent CD8 + T cell activation, leading to the production of both pro-and antiinflammatory cytokines, is an underappreciated part of the innate immune response and may have important physiologic implications for bystander cells in the vicinity. 
IL
CD69
+ , suggesting they were recently activated effector cells (Fig. 3A and  B) . Furthermore, these cells had low expression of CD127 and a high proportion of them expressed KLRG1, consistent with terminally differentiated effectors (Fig. 3A and B) . In contrast, 2 memory precursors, and a few terminally differentiated effectors ( Fig. 3A and B) . Among Agexperienced CD44 + hepatic CD8 + T cells, those producing IL-10 had greater expression of T bet, a key transcription factor driving terminal effector differentiation, compared with their IL-10 2 counterparts (Fig. 3C) . IL-10/GFP +
CD8
+ T cells also demonstrated relative up-regulation of eomesodermin, which is induced shortly after T cell activation (Fig. 3C ) [28] . Interestingly, IL-10/GFP + hepatic CD8 + T cells tended to have greater expression of both T bet and eomesodermin than control bona fide effector CD8 + T cells from LCMV-infected mice (Fig. 3C) . This difference may be a reflection of the different organs and inflammatory inducers used in these 2 systems but may also identify a characteristic distinguishing IL-10 + hepatic CD8 + T cells from conventional effector CD8 + T cell populations. h in culture (Fig. 4C ). The addition of BMDCs activated with CpG, TCR stimulation, exogenous cytokines, or serum from a TLR9-MAS mouse failed to rescue the viability of IL-10/GFP + CD8 + T cells (Fig. 4B and C) . It is possible that the viability of IL-10 + hepatic CD8 + T cells may be better preserved in situ, where supportive anatomic compartments within the liver, such as those formed by intrahepatic myeloid-cell aggregates for T cell population expansion [29] , are induced by administration of CpG or other inflammatory stimuli. However, our findings are also consistent with work by the Crispe laboratory (University of Washington, Seattle, WA, USA) demonstrating selective retention of activated, apoptotic CD8 + T cells in the liver [30] . Together, these findings show that IL-10 + hepatic CD8 + T cells in TLR9-MAS mice display a phenotype and high degree of turnover, resembling that of short-lived effector cells. (Fig. 5A) . The most down-regulated genes were notable for several chemokine receptors (S1pr1, Cxcr5, Ccr7) and other genes typically expressed at low levels in effector CD8 + T cells (Il7r, Actn1) (Fig. 5A) [33, 34] . These data suggest that IL- 
10
+ hepatic CD8 + T cells are programmed to circulate through nonlymphoid tissues, consistent with their accumulation in the liver. A number of up-regulated genes were regulators of cell cycle (e.g., Ccnb1; Fig. 5A ), similar to more putative upstream regulators identified by IPA, including FOXM1, MYC, S100A6, CCND1, MAPK1 (predicted activation; Table 1 ) and TP53, CDKN2A, CDKN1A, RBL1 (predicted inhibition; Table 1 T cells has hepatotoxic potential because hepatocytes constitutively express Fas and are thus highly susceptible to apoptosis [35, 36] . Fas/FasL signaling has also been implicated in the liver damage observed in murine FHL [37] , raising the possibility of a similar mechanism in TLR9-MAS.
As an alternative analytic approach, we entered our differentially expressed gene list into the Database for Annotation, Visualization and Integrated Discovery (National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA) and performed a clustering analysis. The results suggested that genes differentially expressed in IL-10 + CD8 + T cells represent altered cell cycle, cell death, and T cell activation status, consistent with our IPA analysis (see Supplemental File). These results point to an effector-like classification for IL-10 + hepatic CD8 + T cells, but we wanted to compare them to a known standard. The Immunologic Genome Project (ImmGen) has generated data on CD8 + T cell subtypes by isolating adoptively transferred OT-I cells from Listeria-OVA-infected mice at different time points postinfection [13] . We performed clustering analysis to compare the transcriptional profiles of our IL-10 + and IL-10 2 CD8 + T cells to those ImmGen CD8 + T cell subsets, using the top 500 genes able to differentiate among ImmGen subsets. Remarkably, the IL-10 + hepatic CD8 + T cells clustered closest to the d-6 ImmGen subset, whereas the IL-10 2 hepatic CD8 + T cells were most similar to naïve CD8 + T cells (Fig. 5B ). These data provide further evidence that IL-10 marks a distinct CD8 + T cell population in the liver which best resembles early effectors, and suggest that not all IL-10-producing CD8 + T cells may be suppressive.
However, IL-10 + hepatic CD8 + T cells were not merely identical to conventional effector cells. Strikingly, their transcriptional profile showed hallmarks of activation by HGF and VEGF ( Fig.  5C and Table 1 ), 2 growth factors highly induced upon hepatic injury [38] . HGF enhances T cell adhesion and promotes leukocyte migration to the liver [39] . VEGF is important for the maintenance of liver sinusoidal endothelial cells, which are specially equipped to recruit lymphocytes to the liver [40] . Thus, the predicted responsiveness of IL-10 + hepatic CD8 + T cells to HGF and VEGF provides evidence that these cells may specifically home to injured liver and undergo transcriptional reprogramming there.
Taken together, these data demonstrate that IL-10 + hepatic CD8 + T cells represent a unique subset of highly activated, Ag-independent, early effector cells induced by systemic inflammation to accumulate within damaged liver, with the potential to contribute to pathogenesis. Further study will not only be important for understanding the role of this particular IL-10 + hepatic CD8 + T cell subset, but may also offer insights that will enable us to dissect mechanisms of inflammatory liver damage in iPALF and other diseases. 
